CardiacSense

About

Headcount over time

Offices

Q&A

What is CardiacSense's primary business?

CardiacSense is an Israeli medical technology company that develops a medical-grade wearable watch for continuous monitoring of heart arrhythmias and vital signs, including blood pressure, heart rate, respiratory rate, and oxygen saturation.

When was CardiacSense founded?

CardiacSense was founded in 2012.

What is the current employee count for CardiacSense?

CardiacSense has 11-50 employees.

Has CardiacSense received FDA clearance for its medical watch?

Yes, CardiacSense received FDA clearance for its medical-grade watch in January 2023.

Did CardiacSense's medical watch participate in any space missions?

In May 2021, CardiacSense's medical watch was selected to remotely monitor the vital signs and general medical condition of Israeli astronauts in space.

When did CardiacSense go public?

CardiacSense completed a Public Offering in February 2021, raising $28,000,000.

What was a significant partnership for CardiacSense in 2020?

In April 2020, Homestay Care (ASX:HSC) partnered with CardiacSense for cardiac wearables.

Team · 16

Eldad Shemesh

Founder · Co-Founder & CEO

Jack Eitan Kyiet

Co-CEO

Liat Shemesh

COO

Guy Ofek

VP R&D

Eyal Copitt

CCO

Prof. Jacob Giris

CMO - Blood Pressure

Prof. Sami Viskin, MD, PhD

Chief Medical Officer, Heart Arrhythmia

Michael Berman

Chairman of the board & Investor

Daniel Naor

Board Member & Investor

Prof. Boris Spektor

Visionary and Head of optical mechanical team

Amarel Boss

Head of Clinical Affairs

Peter Sugarman

Board Member

Yaniv Inbar

VP Operations

Meni Itzhak

VP R&D

Amnon Blanca

Director of Business Development

Miki Ben-Nun

Sales Manager

Sectors & technology

Highlights

Tags